The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Balanced replies in fairness from you all . Thanks. I did sell some of my holding on Friday but retain a reasonable amount in case pyc do come good which I hope it does. Gonna buy in different sectors. I'm fed up of waiting with the likes of val and sar and in fact pyc too. So at least now I won't get wound up with non action. Sold half of sar and val holdings too at least I've slept better best wishes to all her that pyc come good
Just a little but harsh! PYC is a very tight knit operation. Last years accounts show only 7 employees. I think we are now at 9. Because of this the BoD is very much hands on and alive to PYC's real situation. The latest NED was in fact an advisor anyway. Because we are extremely specialised we have a very targeted approach. This can be a danger of course but Cancer research is now getting massive attention and PYC is ideally poised to benefit. Wait for the June accounts and perhaps re-think your opinion?
Outlook
The Directors believe the Company is in a very strong position to meet market expectations for this year as it continues to make good progress in each of its key business areas.
The year end is June 30th,and as far as I can see they have delivered what they said they would over the last 9mths and on course for record figures
The share prices of most companies over the last 4mths do not reflect the progress made, and for example PYC had a large buy on Friday at full price of 3.9p and yet the market makers did not reflect that In the share price
When I checked late Friday there was about 75,000 shares available..
Sienna you have £100 worth of shares.
Stop panicking you either loss 100 quid or gain Hundreds.
Not much risk Vs reward.
So chill.
You are staying this about the BOD - have you ever contacted them? Asked questions and have open dialogue? No thought not.
I can see that you feel that way about most of your shares on Friday ( SAR VAL ARCL etc)
This appears to be a very tough market which is why I'm positioned in Hugh yield or non discretionary companies in medicine tech
Oncology spending will continue throughout this difficult economy and I believe SCLP and PYC will continue to attract investment
JOKE!!!!!
Truro, last year you had a feeling it would be a milestone year for PYC. The share price now languishes sub 4p, why are you still predicting things and talking about your feelings?
Yep, some womble paid of just over 250k this morning, way above the offer price at the time, only to sell out a few hours later. Give your head a wobble!! At least another 250k buy went thru shortly after.
All this for a 4mcap coy.
Last June year end was preceded by an April update that sugared the pill a little. Although sales were not as expected because of Covid drag other positive measures were announced. This year will be different as my guess is that record revenues will get us close to breakeven if not in profits. However my interest will be on the progress of the various business streams. If these are positive then I feel that we may well see an SP increase to reflect this and 6/7p may well be achievable because although our basic running costs will have risen because of head count increases our other costs are pretty stable. Hopefully get an update in some 6 weeks or so?
Got a good feeling about this company - it's in the right oncology sector at a time when personalised medical drugs are being researched in a wide and growing area. Onwards and upwards folks!
was it the buyer/seller who sold at c500.00 loss ?
Where has it been publicly stated that I'm share14 on advfn?
S4, i must take umbridge with your post re mental health.
As far as i can see, there are a few that are making the correlation between the 2 names?
On the ADVF site, you have also made that correlation, and have mocked the 2 names, how can you appear to be genuine in your condemnation of the insinuation here, whilst mocking and fueling the same insinuation elsewhere?
How can you say its no laughing matter here, when elsewhere you have mocked it?
You are right, Mental Health is no laughing matter.
"Hardly anyone posts on the PYC lse forum so how that tool thought it wasn't obvious who it is when a 'new' poster starts cutting and pasting RNSes on a daily basis is beyond me. Riddlaura's imaginary "husband" needs to be filing for a divorce pronto before they go bankrupt." was posted by S4 1st June 2022 at 1540.
How do you know that R left all sites due to mental health? As far as i can see, there is nothing stated publicly about such a statement.
Lack Kidlington; ….
looks like our TR1 holder is at
@KingsCollegeLon
as senior research fellow.
@christian_hurry
also works there, he was named in a research paper here: https://physiomics.co.uk/portfolio-item/a-precision-dosing-application-for-patients-treated-with-docetaxel-and-g-csf/ in 2021.
All buys yesterday, albeit only 147k's worth. No 30k sells.
Wye, whats a leak of investment?
Laura2022, do you know Riddler? You should be introduced as you appear to share the same corporate values. Since when has low cash burn automatically meant good for annual results? Low cash burn for established companies is good but for developing organisations it shows a leak of investment and therefore progress I’m my opinion.
Businesses recruit when they have a demand due to existing or forthcoming contracts.
You can pursue new business streams all you want, doesn't mean you'll get them.
In the past there was not a lot of recruitment, but in the last couple of years this has changed, as has the company, in that we are pursuing new business streams. I'm not saying we are recession proof but cancer and personalised medicine research does seem to be in a critical stage with many companies involved.
The recent recruitments, including a NED, show the confidence of the BoD. Personally I think this confidence is justified and I'm looking forward to a full year trading update in a couple of months or so. Onwards and upwards!
The company clearly stated that since mid 2021 they have decided to spend money on recruitment and development, hence why in the financial year June 2021 onwards there was more spending from the company due to growth and expansion
>Our cash position is pretty stable. In the full year ended 30 June 2021 our net change in cash was a reduction of just ~£5k. In each of the last two full financial years we’ve maintained cash and equivalents of over £1m. Now we may choose selectively to make some investments from that cash pile (as we have done in hiring a new BD lead for example), but we want to be cautious and leave ourselves a reserve float just in case of unexpected circumstances
See the annual accounts
The extra spend was on recruitment of 3+ new personal which they chose and planned to spend
The Costs of the operating business (net cash used I operating activities) is c £40k
riddler's always good at gloss
From the last annual accounts & interims:
Cash and cash equivalents at 30 June 2021 of £1,043,450
Cash and cash equivalents of £794k at 31 December 2021
So, in 6 months cash decreased by around £250k. How do you get cash burn of '£30k or so per annum'?
Is is very very poor volume across the whole market....the £3.8mln cap does not reflect the progress here
We have a very very low cash burn (£30k or so per annum) amd therefore PYC are in far better position than most small caps as PYC has 1/4 of the value as cash and we knowbthat the VAL201 deal is coming as shown in the VAL annual report
There are 100s of stocks also suffering from low liquidity
Sienna
What did you ask/email to PYC ?